Skip to main content
TipRanks
Go Ultimate75% OFF

AbCellera Biologics (ABCL) Q3 2022 Earnings Report

2,565 Followers

ABCL Q3 2022 EPS Results

Actual EPS
$0.08
Consensus EPS
$0.06
Beat/Miss
Beat by +$0.02
One Year Ago EPS
-$0.08

ABCL Q3 2022 Revenue Results

Actual Revenue
$101.38M
Expected Revenue
$74.96M
Beat/Miss
Beat by +$26.42M
YoY Revenue Growth
+1740.65%

Earnings Announcement Details

Quarter
Q3 2022
Date
11/08/2022
Time
After Close
Conference Call
Tuesday, November 8, 2022
ABCL Upcoming Earnings

AbCellera Biologics's next earnings date is estimated for February 23, 2027, based on past reporting schedules.

Q3 2022 Earnings Call Audio

ABCL Q3 2022 Earnings Call
0:00 / 0:00

Q3 2022 Earnings Slide Deck

Q3 2022 Earnings Call Summary

No earnings call summary is available for this earnings event.

ABCL Earnings History

ABCL earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 23, 20272026 (Q4)-0.15--0.03――
Nov 09, 20262026 (Q3)-0.17-0.13-0.1931.58% (+0.06)
Aug 05, 20262026 (Q2)-0.16-0.18-0.12-50.00% (-0.06)
May 11, 20262026 (Q1)-0.17-0.14-0.156.67% (+0.01)
Feb 24, 20262025 (Q4)-0.13-0.03-0.1275.00% (+0.09)
Nov 06, 20252025 (Q3)-0.14-0.19-0.17-11.76% (-0.02)
Aug 07, 20252025 (Q2)-0.13-0.12-0.137.69% (+0.01)
May 08, 20252025 (Q1)-0.14-0.15-0.14-7.14% (-0.01)
Feb 27, 20252024 (Q4)-0.13-0.12-0.1625.00% (+0.04)
Nov 04, 20242024 (Q3)-0.12-0.17-0.1-70.00% (-0.07)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed